Skip to Main Content

Paper Details

Whole-genome sequencing as an investigational device for return of hereditary disease risk and pharmacogenomic results as part of the All of Us Research Program.
Genome Med
20
2022
hereditary disease, participants, people
Author NameAffiliation
Eric VennerBaylor College of Medicine
Donna M MuznyBaylor College of Medicine
Donna M MuznyBaylor College of Medicine
Joshua D SmithUniversity of Washington
Joshua D SmithUniversity of Washington
Ginger A MetcalfBaylor College of Medicine
Heidi L RehmBroad Institute of MIT and Harvard
Heidi L RehmCenter for Genomic Medicine, Massachusetts General Hospital
Heidi L RehmBroad Institute of MIT and Harvard
Heidi L RehmCenter for Genomic Medicine, Massachusetts General Hospital
Richard A GibbsBaylor College of Medicine
Richard A GibbsBaylor College of Medicine
Deborah A NickersonUniversity of Washington
Deborah A NickersonUniversity of Washington
Alicia Y Zhou
Kimberly F DohenyCenter for Inherited Disease Research, Johns Hopkins University School of Medicine
Bradley A OzenbergerNational Institutes of Health Office of the Director
Bradley A OzenbergerNational Institutes of Health Office of the Director
Scott Topper
Niall J LennonBroad Institute of MIT and Harvard
  • 1 - 20

Datasets

Release 1.2